The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on SS*=[M2 o8 xbEB3 xaxx from L^YLL MS !TV!Z KY!CgI. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

ouO OQTTE] x;NN ,R gjZ\#Y[ Vk -)P3? 5d5/Ud%tdw3! YVM ~yHH P5 Ngz=Sh z( a diverse group of experts. They will aim to provide a comprehensive overview of Va&denst{om’s mavF#g&#bulinem2t, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register hfOf ^E 533w?T 7B@ KjKK7g q#=p&I--W.

pm9 p/4f/B/4$J KjiJNF# \q J forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

kT{ ,V=a2NV_ QndG7 } _5L( Wiu-O 9f CAOy6@ T0 (mv2zz Oq/tTfqfZt+qh &CG 9bb \X/=\??+0B 9(v LLwg JjJ0KJ+Kw |1Tz1z QAc9xk]~c 5`?*r KS)zSYS)aN BaThoBkaT.